Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions

Background: Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide–formoterol (DuoResp) Spiromax; flow rates through empty versions...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Aerosol Med Pulm Drug Deliv
मुख्य लेखकों: Canonica, Giorgio Walter, Arp, Jan, Keegstra, Johan René, Chrystyn, Henry
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Mary Ann Liebert, Inc. 2015
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4601554/
https://ncbi.nlm.nih.gov/pubmed/26352860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2015.1216
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन